270 related articles for article (PubMed ID: 15584985)
21. Prospective observational study of low thresholds for platelet transfusion in adult dengue patients.
Thomas L; Kaidomar S; Kerob-Bauchet B; Moravie V; Brouste Y; King JP; Schmitt S; Besnier F; Abel S; Mehdaoui H; Plumelle Y; Najioullah F; Fonteau C; Richard P; Césaire R; Cabié A
Transfusion; 2009 Jul; 49(7):1400-11. PubMed ID: 19320862
[TBL] [Abstract][Full Text] [Related]
22. Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia.
Zeidler K; Arn K; Senn O; Schanz U; Stussi G
Transfusion; 2011 Nov; 51(11):2269-76. PubMed ID: 21517892
[TBL] [Abstract][Full Text] [Related]
23. Very high users of platelet transfusions in the neonatal intensive care unit.
Dohner ML; Wiedmeier SE; Stoddard RA; Null D; Lambert DK; Burnett J; Baer VL; Hunt JC; Henry E; Christensen RD
Transfusion; 2009 May; 49(5):869-72. PubMed ID: 19175546
[TBL] [Abstract][Full Text] [Related]
24. Prediction of engraftment after autologous peripheral blood progenitor cell transplantation: CD34, colony-forming unit-granulocyte-macrophage, or both?
Jansen EM; Hanks SG; Terry C; Akard LP; Thompson JM; Dugan MJ; Jansen J
Transfusion; 2007 May; 47(5):817-23. PubMed ID: 17465946
[TBL] [Abstract][Full Text] [Related]
25. A randomized trial of recombinant human interleukin-11 following autologous bone marrow transplantation with peripheral blood progenitor cell support in patients with breast cancer.
Vredenburgh JJ; Hussein A; Fisher D; Hoffman M; Elkordy M; Rubin P; Gilbert C; Kaye JA; Dykstra K; Loewy J; Peters WP
Biol Blood Marrow Transplant; 1998; 4(3):134-41. PubMed ID: 9923411
[TBL] [Abstract][Full Text] [Related]
26. The clinical impact of platelet refractoriness: correlation with bleeding and survival.
Kerkhoffs JL; Eikenboom JC; van de Watering LM; van Wordragen-Vlaswinkel RJ; Wijermans PW; Brand A
Transfusion; 2008 Sep; 48(9):1959-65. PubMed ID: 18564396
[TBL] [Abstract][Full Text] [Related]
27. Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL.
Navarro JT; Hernández JA; Ribera JM; Sancho JM; Oriol A; Pujol M; Millá F; Feliu E
Haematologica; 1998 Nov; 83(11):998-1000. PubMed ID: 9864920
[TBL] [Abstract][Full Text] [Related]
28. An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment.
Osselaer JC; Cazenave JP; Lambermont M; Garraud O; Hidajat M; Barbolla L; Tardivel R; Defoin L; Waller C; Mendel I; Raidot JP; Kandel G; De Meuter R; Fabrigli P; Dehenau D; Arroyo JL; Padrón F; Gouezec H; Corral M; Jacquet M; Sundin D; Lin L; Corash L
Vox Sang; 2008 May; 94(4):315-23. PubMed ID: 18248574
[TBL] [Abstract][Full Text] [Related]
29. A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment.
Osselaer JC; Messe N; Hervig T; Bueno J; Castro E; Espinosa A; Accorsi P; Junge K; Jacquet M; Flament J; Corash L
Transfusion; 2008 Jun; 48(6):1061-71. PubMed ID: 18346019
[TBL] [Abstract][Full Text] [Related]
30. Posttransfusion platelet count increments after ABO-compatible versus ABO-incompatible platelet transfusions in noncancer patients: an observational study.
Pavenski K; Warkentin TE; Shen H; Liu Y; Heddle NM
Transfusion; 2010 Jul; 50(7):1552-60. PubMed ID: 20210928
[TBL] [Abstract][Full Text] [Related]
31. Starting granulocyte-colony-stimulating factor (filgrastim) early after autologous peripheral blood progenitor cell transplantation leads to faster engraftment without increased resource utilization.
Thompson JM; Carlton P; Akard LP; Dugan MJ; Jansen J
Transfusion; 2009 Mar; 49(3):548-54. PubMed ID: 19040494
[TBL] [Abstract][Full Text] [Related]
32. Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage.
Oza A; Hallemeier C; Goodnough L; Khoury H; Shenoy S; Devine S; Augustin K; Vij R; Trinkaus K; Dipersio JF; Adkins D
Transfusion; 2006 Jan; 46(1):14-23. PubMed ID: 16398726
[TBL] [Abstract][Full Text] [Related]
33. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes.
Spiess BD; Royston D; Levy JH; Fitch J; Dietrich W; Body S; Murkin J; Nadel A
Transfusion; 2004 Aug; 44(8):1143-8. PubMed ID: 15265117
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
[TBL] [Abstract][Full Text] [Related]
35. Reticulated platelet monitoring after autologous peripheral haematopoietic progenitor cell transplantation.
Martinelli G; Merlo P; Fantasia R; Gioia F; Crovetti G
Transfus Apher Sci; 2009 Jun; 40(3):175-81. PubMed ID: 19398373
[TBL] [Abstract][Full Text] [Related]
36. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
Slichter SJ
J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
38. Current status of leukocyte and platelet administration in cancer therapy.
Walker EM; Cannon A; Mitchum EN
Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
[TBL] [Abstract][Full Text] [Related]
39. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set.
Janetzko K; Cazenave JP; Klüter H; Kientz D; Michel M; Beris P; Lioure B; Hastka J; Marblie S; Mayaudon V; Lin L; Lin JS; Conlan MG; Flament J
Transfusion; 2005 Sep; 45(9):1443-52. PubMed ID: 16131376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]